Increased expression of α-melanocyte-stimulating hormone in the lesional skin of melasma [8]

British Journal of Dermatology

Volumn 146, Issue 1, 2002, Pages 165-167

  Im, S ^a   Kim, J ^a   On, W Y ^a   Kang, Won Hyoung ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; MELANOCORTIN 1 RECEPTOR; PROOPIOMELANOCORTIN;

ADULT; CHLOASMA; CLINICAL ARTICLE; CYTOPLASM; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; LETTER; MELANOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SKIN BIOPSY; SKIN DEFECT; SUN EXPOSURE;

ADULT; FEMALE; HUMANS; MELANOCYTE-STIMULATING HORMONES; MELANOSIS; MIDDLE AGED;

EID: 0036180249     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.4513_3.x     Document Type: Letter

References (6)

1. Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation
2. The melanocortin-1 receptor and human pigmentation
3. Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients
4. Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ
5. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes
6. UVB-induced melanogenesis may be mediated through the MSH-receptor system